110 related articles for article (PubMed ID: 23230603)
21. [Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation].
Miki T; Miura T; Tsuchida A; Nakano A; Hasegawa T; Fukuma T; Shimamoto K
J Cardiol; 2001 Feb; 37(2):112-3. PubMed ID: 11255694
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes. The critical role of Ca(2+)-dependent signaling.
Sadoshima J; Qiu Z; Morgan JP; Izumo S
Circ Res; 1995 Jan; 76(1):1-15. PubMed ID: 8001266
[TBL] [Abstract][Full Text] [Related]
23. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts.
Maulik N; Watanabe M; Zu YL; Huang CK; Cordis GA; Schley JA; Das DK
FEBS Lett; 1996 Nov; 396(2-3):233-7. PubMed ID: 8914993
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II-induced phosphorylation of the AT1 receptor from rat brain neurons.
Yang H; Lu D; Raizada MK
Hypertension; 1997 Sep; 30(3 Pt 1):351-7. PubMed ID: 9314416
[TBL] [Abstract][Full Text] [Related]
25. Retracted: Caveolin and MAP kinase interaction in angiotensin II preconditioning of the myocardium.
Das M; Das S; Das DK
J Cell Mol Med; 2012 Oct; 16(10):2547. PubMed ID: 23189334
[No Abstract] [Full Text] [Related]
26. Angiotensin II-preconditioning is associated with increased PKCε/PKCδ ratio and prosurvival kinases in mitochondria.
Nuñez RE; Javadov S; Escobales N
Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1201-1212. PubMed ID: 28707739
[TBL] [Abstract][Full Text] [Related]
27. Arsenic causes aortic dysfunction and systemic hypertension in rats: Augmentation of angiotensin II signaling.
Waghe P; Sarath TS; Gupta P; Kandasamy K; Choudhury S; Kutty HS; Mishra SK; Sarkar SN
Chem Biol Interact; 2015 Jul; 237():104-14. PubMed ID: 26079204
[TBL] [Abstract][Full Text] [Related]
28. Role of angiotensin in cardioprotective effect of ischemic preconditioning.
Sharma A; Singh M
J Cardiovasc Pharmacol; 1999 May; 33(5):772-8. PubMed ID: 10226865
[TBL] [Abstract][Full Text] [Related]
29. Retraction notice to "Long-Term Trends (1986-2003)in the Use of Coronary Reperfusion Strategies in Patients Hospitalized With Acute Myocardial Infarction in Central Massachusetts" [Int. J Cardiol. 131 (2008) (83-89)].
Goldberg RJ; Spencer FA; Okolo J; Lessard D; Yarzebski J; Gore JM
Int J Cardiol; 2017 May; 235():207. PubMed ID: 28342504
[TBL] [Abstract][Full Text] [Related]
30. Possible mechanism of cardioprotective effect of angiotensin preconditioning in isolated rat heart.
Sharma A; Singh M
Eur J Pharmacol; 2000 Oct; 406(1):85-92. PubMed ID: 11011038
[TBL] [Abstract][Full Text] [Related]
31. Cell survival signalling in heart derived myofibroblasts induced by preconditioning and bradykinin: the role of p38 MAP kinase.
Cooper M; Ytrehus K
Mol Cell Biochem; 2004 Apr; 259(1-2):83-90. PubMed ID: 15124911
[TBL] [Abstract][Full Text] [Related]
32. Reperfusion kinase phosphorylation is essential but not sufficient in the mediation of pharmacological preconditioning: Characterisation in the bi-phasic profile of early and late protection.
Bell RM; Clark JE; Hearse DJ; Shattock MJ
Cardiovasc Res; 2007 Jan; 73(1):153-63. PubMed ID: 17126307
[TBL] [Abstract][Full Text] [Related]
33. Redox signaling in remote ischemic preconditioning-induced cardioprotection: Evidences and mechanisms.
Singh L; Randhawa PK; Singh N; Jaggi AS
Eur J Pharmacol; 2017 Aug; 809():151-155. PubMed ID: 28526338
[TBL] [Abstract][Full Text] [Related]
34. Role of the actin cytoskeleton in angiotensin II signaling in human vascular smooth muscle cells.
Touyz RM; Yao G; Schiffrin EL
Can J Physiol Pharmacol; 2005 Jan; 83(1):91-7. PubMed ID: 15759055
[TBL] [Abstract][Full Text] [Related]
35. Retraction notice to “Dual ACE-inhibition and angiotensin II AT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarction in rat heart” [Eur.J.Pharmacol.January(2015)22–30].
Eur J Pharmacol; 2015 Aug; 761():423. PubMed ID: 26478933
[No Abstract] [Full Text] [Related]
36. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
[TBL] [Abstract][Full Text] [Related]
37. Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure.
Booz GW; Day JN; Baker KM
J Mol Cell Cardiol; 2002 Nov; 34(11):1443-53. PubMed ID: 12431443
[TBL] [Abstract][Full Text] [Related]
38. Notice of Retraction. Shimizu et al. Association of Genetic and Clinical Aspects of Congenital Long QT Syndrome With Life-Threatening Arrhythmias in Japanese Patients. JAMA Cardiol. 2019;4(3):246-254.
Shimizu W; Aiba T
JAMA Cardiol; 2021 Jun; 6(6):727. PubMed ID: 33900377
[No Abstract] [Full Text] [Related]
39. Regulation of sarcolemmal Na(+)/H(+) exchanger activity by angiotensin II in adult rat ventricular myocytes: opposing actions via AT(1) versus AT(2) receptors.
Gunasegaram S; Haworth RS; Hearse DJ; Avkiran M
Circ Res; 1999 Nov; 85(10):919-30. PubMed ID: 10559139
[TBL] [Abstract][Full Text] [Related]
40. Role of cardiac renin angiotensin system in ischemia reperfusion injury and preconditioning of heart.
Agrawal V; Gupta JK; Qureshi SS; Vishwakarma VK
Indian Heart J; 2016; 68(6):856-861. PubMed ID: 27931559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
